Buddha of Swat smiles nearly 11 years after Taliban dynamited it

Agencies
July 13, 2018

Peshawar, Jul 13: The iconic Buddha of Swat, carved on a cliff in the 7th century, has been restored to its almost original form with Italian assistance in the troubled northwestern Pakistan, nearly 11 years after it was dynamited by the banned Tehreek-e-Taliban Pakistan during their control over the area.

Buddha seated in a meditative posture, which is considered one of the largest rock sculptures in South Asia, was attacked in September 2007 by the Taliban militants, who blew up half the statue's face by drilling holes into the face and shoulders and inserting explosives, triggering a worldwide anger.

The Italian government invested 2.5 million euros (USD 2.9 million) in five years to preserve the cultural heritage and restore the six-metre tall Buddha of Swat, depicted in a lotus position at the base of a granite cliff.

Luca Maria Olivieri, an Italian archaeologist who oversaw the restoration of the Buddha of Swat, said the rehabilitation of the site has not been easy.

The Italian Archaeologist said the reconstruction is not identical, but that is deliberate, as "the idea of damage should remain visible".

The restoration started in 2012 in phases with the application of a coating to protect the damaged part of the sculpture. The reconstruction of the face itself was first prepared virtually in the laboratory, in 3D, using laser surveys and old photos.

The last phase, the actual restoration of Buddha of Swat, ended in 2016. 

Now the authorities are counting on Buddha's recovered smile and iconic status to boost religious tourism from places such as China and Thailand, he added.

The Italian government has been helping to preserve hundreds of archaeological sites in the northwestern Pakistan, working with local authorities who hoped to turn it into a place of interest for history-loving people and make it a local and foreign tourism attraction place.

In 2007, the Taliban militants under the leadership of Mullah Fazlullah gained effective control of much of Swat, a picturesque valley in the Khyber Pakhtunkhwa province of Pakistan. The militants banned dancing, parties and music shops, and also destroyed more than 400 schools.

In 2009, the Pakistani Army launched an operation 'Rah-e-Rast' to flush out militants from the tribal region.

Mullah Fazlullah, the dreaded chief of Tehreek-e-Taliban Pakistan, was killed in a US drone attack in Afghanistan's restive Kunar province last month.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 9,2020

Mumbai, Mar 9: India's Yes Bank will not be merged with State Bank of India, which is set to infuse funds in the beleaguered lender, the newly appointed administrator leading the rescue plan said in a television interview on Monday.

"There is absolutely no question of a merger," Prashant Kumar, the administrator, told the CNBC TV18 channel.

The Reserve Bank of India (RBI) on Thursday took control of Yes Bank, after the lender - which is laden with bad debts - failed to raise the capital it needs to stay above mandated regulatory requirements.

Placing Yes Bank under a 30-day moratorium, the central bank imposed limits on withdrawals to protect depositors and said it would work on a revival plan. The move spooked depositors, who rushed to withdraw funds from the bank.

Kumar, a former finance chief at SBI, assured depositors their money was safe and that the moratorium on Yes Bank might be lifted much before the deadline on April 3 and normal banking operations might resume as early as Friday.

He also mentioned that the withdrawal limit of Yes Bank may be removed by March 15, 2020.

SBI Chairman Rajnish Kumar said on Saturday the state-run bank would need to invest up to 24.5 billion rupees ($331 million) to buy a 49% stake in Yes Bank as part of the initial phase of the rescue deal, adding that the survival of troubled lender was a "must".

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 17,2020

New Delhi, Feb 17: Two alleged criminals were killed in an exchange of fire with the Special Cell of Delhi Police at Pul Pehlad Pur area in New Delhi on Monday morning, officials said.

The encounter took place around 5 am, they said.

Raja Qureshi and Ramesh Bahadur, who were injured during the encounter, were rushed to a nearby hospital, where they were declared brought dead by doctors, Deputy Commissioner of Police (Special Cell) P S Kushwah said.

According to police, the two men were involved in multiple cases of murder and robbery.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.